Standout Papers

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors 2018 2026 2020 2023 559
  1. Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors (2018)
    Ming Yi, Dechao Jiao et al. Molecular Cancer
  2. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment (2019)
    Ming Yi, Dechao Jiao et al. Molecular Cancer
  3. Tumor organoids: applications in cancer modeling and potentials in precision medicine (2022)
    Hanxiao Xu, Dechao Jiao et al. Journal of Hematology & Oncology

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
1 intermediate paper

Works of Dechao Jiao being referenced

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
2022
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
2022

Author Peers

Author Last Decade Papers Cites
Dechao Jiao 985 503 226 1371 816 136 3.0k
Chang Ohk Sung 816 721 180 1703 1367 138 3.9k
Urban Emmenegger 896 254 186 1529 1352 147 3.4k
Hisakazu Yamagishi 993 1266 238 1270 1629 216 4.4k
Cindy Neuzillet 636 601 170 2108 1215 131 3.4k
Hiroyuki Shinchi 576 740 218 1635 665 103 2.6k
Kosei Maemura 806 906 205 1599 1123 158 3.3k
Minoru Kitago 693 1069 533 1799 1045 189 3.7k
Suxia Luo 765 281 78 1918 1236 105 3.3k
Jonathan D. Schoenfeld 1135 706 70 2504 620 139 3.9k
Xinwei Han 681 653 296 537 972 156 3.0k

All Works

Loading papers...

Rankless by CCL
2026